Aster DM Healthcare to host investor meets in Hong Kong, Singapore
Aster DM Healthcare Limited has announced analyst and investor meets in Hong Kong and Singapore on June 8-9, 2026, as part of the Kotak India Corporate Day. The sessions will include group conferences and one-on-one meetings, with no unpublished price sensitive information to be disclosed. The schedule is subject to change based on exigencies.

*this image is generated using AI for illustrative purposes only.
Aster DM Healthcare Limited has scheduled a series of analyst and institutional investor meets in Hong Kong and Singapore for June 8 and June 9, 2026. The company will participate in these sessions through its representatives as part of the Kotak India Corporate Day. The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The meetings will include both conference meets for investor groups and one-on-one interactions. The company stated that no unpublished price sensitive information would be shared during these events. The schedule is subject to change based on exigencies involving investors, analysts, or the company.
The details of the scheduled events are as follows:
| Name of Event(s) | Type of Meet(s) | Date of Meet(s) | Time of Meet(s) | Mode and Place of Meet(s) |
|---|---|---|---|---|
| Kotak India Corporate Day | Conference Meet [Investor Group and One to One] | June 8, 2026 | 9:00 AM to 5:00 PM (HKT) 6:30 AM to 2:30 PM (IST) |
In-Person at Hong Kong |
| Kotak India Corporate Day | Conference Meet [Investor Group and One to One] | June 9, 2026 | 9:00 AM to 5:00 PM (SGT) 6:30 AM to 2:30 PM (IST) |
In-Person at Singapore |
The intimation was signed by Hemish Purushottam, Company Secretary and Compliance Officer of Aster DM Healthcare Limited.
Historical Stock Returns for Aster DM Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.49% | -1.45% | +4.20% | +11.45% | +32.30% | +398.29% |
What strategic growth initiatives does Aster DM Healthcare plan to highlight during these investor meets?
How might the outcomes of these interactions influence institutional investor sentiment towards the healthcare sector?
Could these meetings signal potential expansion plans or partnerships in the Asian markets?


































